Persistent and Poor-Responsive Cystoid Macular Edema after Stereotactic Radiotherapy in Neovascular Age-Related Macular Degeneration: A Case Report of Three Patients

Filippo Billia; Katja Hatz-Wurziger

doi:10.1055/a-2276-6309

Klinische Monatsblätter für Augenheilkunde, Table of Contents

CC BY-NC-ND 4.0 · Klin Monbl Augenheilkd 2024; 241(04): 459-462
DOI: 10.1055/a-2276-6309

Der interessante Fall

Persistent and Poor-Responsive Cystoid Macular Edema after Stereotactic Radiotherapy in Neovascular Age-Related Macular Degeneration: A Case Report of Three Patients

Persistierendes und schlecht ansprechendes zystoides Makulaödem nach stereotaktischer Strahlentherapie bei neovaskulärer altersabhängiger Makuladegeneration: ein Fallbericht von 3 Patienten

Filippo Billia

¹Ophthalmology, Vista Augenklinik Binningen, Switzerland

²Ophthalmology, Avanti Clinica Oculistica, Lugano, Switzerland

,

Katja Hatz-Wurziger

¹Ophthalmology, Vista Augenklinik Binningen, Switzerland

³Ophthalmology, Faculty of Medicine, University of Basel, Switzerland

› Author Affiliations

Abstract

Full Text

References

References
1 Jackson TL, Chakravarthy U, Slakter JS. et al. INTREPID Study Group. Stereotactic radiotherapy for neovascular age-related macular degeneration: year 2 results of the INTREPID study. Ophthalmology 2015; 122: 138-145
2 Hatz K, Zimmermann F, Kardamakis D. et al. Low-Energy Stereotactic Radiotherapy for Treatment of Exudative Age-Related Macular Degeneration in a Treat-and-Extend Regimen. Ophthalmic Surg Lasers Imaging Retina 2018; 49: 86-93
3 Cantley JL, Hanlon J, Chell E. et al. Influence of eye size and beam entry angle on dose to non-targeted tissues of the eye during stereotactic x-ray radiosurgery of AMD. Phys Med Biol 2013; 58: 6887-6896
4 Freiberg FJ, Michels S, Muldrew A. et al. Microvascular abnormalities secondary to radiation therapy in neovascular age-related macular degeneration: findings from the INTREPID clinical trial. Br J Ophthalmol 2019; 103: 469-474
5 Hatz K, Zimmermann F, Lazaridis E. et al. Microvascular abnormalities and long-term efficacy after stereotactic radiotherapy under continued intravitreal anti-VEGF treatment for neovascular AMD. Br J Ophthalmol 2022; 106: 415-421
6 Evans JR, Igwe C, Jackson TL. et al. Radiotherapy for neovascular age‐related macular degeneration. Cochrane Database Syst Rev 2020; (08) CD004004
7 Hoffmann L, Hatz K. External Limiting Membrane Disruption Predicts Long-Term Outcome in Strict Treat-And-Extend Regimen in Neovascular Age-Related Macular Degeneration. Front Med (Lausanne) 2021; 8: 706084
8 Steinemann A, Hoffmann L, Hatz KB. Polypoidal Choroidal Vasculopathy after Stereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration: A Case Report with Long-Term Follow-Up. Case Rep Ophthalmol 2021; 12: 299-305
9 Prasuhn M, Kurz M, Grisanti S. et al. Three-year clinical and optical coherence tomography follow-up after stereotactic radiotherapy for neovascular age-related macular degeneration. Adv Med Sci 2021; 66: 215-220
10 Fallico M, Chronopoulos A, Schutz JS. et al. Treatment of radiation maculopathy and radiation-induced macular edema: A systematic review. Surv Ophthalmol 2021; 66: 441-460